LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 30.64 | 17.25 | 893 | 1887 | 0.4731 | 0.7908 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 30.64 | 17.25 | 1327 | 1887 | 0.7031 | 0.8986 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 32.61 | 17.25 | 1049 | 2136 | 0.4910 | 0.8055 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 32.61 | 17.25 | 1107 | 2136 | 0.5182 | 0.8195 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 32.61 | 17.25 | 931 | 2136 | 0.4358 | 0.7748 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 32.61 | 17.25 | 1351 | 2136 | 0.6324 | 0.8724 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 34.57 | 17.25 | 1046 | 2523 | 0.4146 | 0.7695 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 34.57 | 17.25 | 1093 | 2523 | 0.4332 | 0.7804 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 34.57 | 17.25 | 1204 | 2523 | 0.4772 | 0.8045 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 34.57 | 17.25 | 1364 | 2523 | 0.5406 | 0.8361 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.54 | 17.25 | 1054 | 2679 | 0.3933 | 0.7594 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.54 | 17.25 | 1088 | 2679 | 0.4060 | 0.7671 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.54 | 17.25 | 1296 | 2679 | 0.4836 | 0.8100 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.54 | 17.25 | 1370 | 2679 | 0.5112 | 0.8239 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.51 | 17.25 | 1096 | 2906 | 0.3771 | 0.7530 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.51 | 17.25 | 1127 | 2906 | 0.3878 | 0.7596 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.51 | 17.25 | 1324 | 2906 | 0.4556 | 0.7983 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 38.51 | 17.25 | 1398 | 2906 | 0.4811 | 0.8116 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 40.48 | 17.25 | 1121 | 3125 | 0.3586 | 0.7445 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 40.48 | 17.25 | 1147 | 3125 | 0.3670 | 0.7498 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 40.48 | 17.25 | 1372 | 3125 | 0.4389 | 0.7921 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 40.48 | 17.25 | 1448 | 3125 | 0.4632 | 0.8050 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 42.45 | 17.25 | 1154 | 3504 | 0.3293 | 0.7303 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 42.45 | 17.25 | 1182 | 3504 | 0.3373 | 0.7357 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 42.45 | 17.25 | 1417 | 3504 | 0.4044 | 0.7772 | MN20160310_N02 | I05 |